Inhibition of herpes simplex virus type 1 DNA polymerase by the natural product oosporein.
Terry
B J
BJ
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey.
Liu
W C
WC
Cianci
C W
CW
Proszynski
E
E
Fernandes
P
P
Bush
K
K
Meyers
E
E
D016227:Benzoquinones / Q000494:pharmacology*; D004279:DNA, Viral / Q000378:metabolism; D004259:DNA-Directed DNA Polymerase; D005090:Exodeoxyribonucleases / Q000037:antagonists & inhibitors*; D006072:Gossypol / Q000494:pharmacology; D006367:HeLa Cells; D006561:Herpes Simplex / Q000201:enzymology*; D006801:Humans; D009183:Mycotoxins / Q000494:pharmacology*; D019384:Nucleic Acid Synthesis Inhibitors; D013379:Substrate Specificity; D014764:Viral Proteins
D016227:Benzoquinones; D004279:DNA, Viral; D009183:Mycotoxins; D019384:Nucleic Acid Synthesis Inhibitors; D014764:Viral Proteins; C008706:oosporein; D004259:DNA-Directed DNA Polymerase; D005090:Exodeoxyribonucleases; C043417:DNA polymerase, Simplexvirus; D006072:Gossypol